Document ID: chunk:federal_register_of_legislation:F2024L00743:reg:9:p2
Version: federal_register_of_legislation:F2024L00743
Segment Type: reg
Provision Reference: reg 9 (pt 2/8)
Character Range: 7474–10896

the time of clinical onset:
(a)          atheroma of the penetrating arteries that arise from the vertebral artery, the basilar artery, the middle cerebral artery stem, and the arteries of the circle of Willis;
(b)          cerebral amyloid angiopathy;
(c)          cerebral arteriolosclerosis;
(d)          cerebral venous thrombosis;
(e)          Moyamoya disease or Moyamoya syndrome;
(f)           Susac syndrome (retinocochleocerebral vasculopathy); or
(g)          Sneddon syndrome;
(14)      having thrombotic thrombocytopaenic purpura, sickle cell disorder or vaccine-induced thrombotic thrombocytopaenia at the time of clinical onset;
(15)      being pregnant within the 6 weeks before clinical onset;
(16)      using one or more of the following drugs within the 72 hours before clinical onset:
(a)          amphetamines and amphetamine-type substances, excluding methylphenidate;
(b)          anabolic-androgenic steroids;
(c)          cocaine;
(d)          D-lysergic acid diethylamide (LSD);
(e)          opioids, including heroin;
(f)           marijuana;
(g)          phencyclidine (angel dust);
(17)      taking a selective serotonin reuptake inhibitor or another serotonergic drug for at least 2 weeks, within the 4 weeks before clinical onset;
(18)      taking an overdose of one or more serotonergic drugs, within the 4 weeks before clinical onset;
(19)      taking a non-topical, non-steroidal, anti-inflammatory drug, excluding aspirin, for a continuous period of at least 30 days before clinical onset, where the last dose of the drug was taken within the 7 days before clinical onset;
Note: non-steroidal, anti-inflammatory drug is defined in the Schedule 1 - Dictionary.
(20)      having heat stroke at the time of clinical onset;
Note: heat stroke is defined in the Schedule 1 - Dictionary.
(21)      being envenomated by a snake, scorpion, box jellyfish, bee, hornet or wasp within the 5 days before clinical onset;
(22)      having active migraine at the time of clinical onset;
Note: active migraine is defined in the Schedule 1 - Dictionary.
(23)      having diabetes mellitus at the time of clinical onset;
(24)      having one of the following cardiac conditions with potential to give rise to a cerebral embolus within the 4 weeks before clinical onset:
(a)          a prosthetic mitral or aortic valve;
(b)          acute myocardial infarction;
(c)          atrial fibrillation and atrial flutter;
(d)          atrial septal aneurysm;
(e)          calcification of the mitral or aortic valve;
(f)           cardiac hydatid cysts;
(g)          cardiomyopathy;
(h)          congestive cardiac failure;
(i)            endocarditis;
(j)            ischaemic, valvular, arrhythmogenic and hypertensive cardiomyopathy;
(k)          Lambl excrescences of the mitral or aortic valve;
(l)            left atrial aneurysm or dilatation;
(m)        left ventricular aneurysm;
(n)          left ventricular dyskinesia;
(o)          mitral valve prolapse;
(p)          primary or secondary cardiac tumours;
(q)          regurgitation of the mitral or aortic valve;
(r)           rheumatic heart disease;
(s)           sick sinus syndrome;
(t)            stenosis of the mitral or aortic valve;
(u)          thrombus within the left atrium or left ventricle; or
(v)          valvulitis of the mitral or aortic valve;
(25)      having one of the following non-cardiac causes of cerebral arterial embolism